Status:
UNKNOWN
Anxiety on the First Day of Chemotherapy
Lead Sponsor:
Namik Kemal University
Conditions:
Breast Cancer
Anxiety
Eligibility:
FEMALE
18-99 years
Phase:
NA
Brief Summary
investigating chemotherapy anxieties
Detailed Description
Breast cancer is the most common type of cancer in women in the world, and it is the first in cancer-related deaths in women all over the world. In the treatment of breast cancer, in addition to surge...
Eligibility Criteria
Inclusion
- to receive chemotherapy for breast cancer for the first time
- give consent for the study
Exclusion
- not approving to participate in the study
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 3 2022
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04839835
Start Date
November 1 2020
End Date
March 3 2022
Last Update
April 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tekirdağ Namık Kemal ÜNiversitesi
Tekirdağ, Turkey (Türkiye), 59100